Genes and attention-deficit hyperactivity disorder

Clinical Neuroscience Research

Volumn 1, Issue 3, 2001, Pages 207-216

  Swanson, James ^a,b   Deutsch, Curtis ^c   Cantwell, Dennis ^a   Posner, Michael ^b   Kennedy, James L ^d   Barr, Cathy L ^d   Moyzis, Robert ^a   Schuck, Sabrina ^a   Flodman, Pamela ^a   Spence, M Anne ^a   Wasdell, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sackler Institute   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Dopamine gene drd4; Refined phenotype

Indexed keywords

EID: 18044403011     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(01)00007-X     Document Type: Article

References (74)

1. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-433.
2. National Institute of Health Consensus Conference on Attention Deficit Hyperactivity Disorder, Washington, DC, 1999.
3. Cantwell DP. Empiricism and child psychiatry. The 1990 C. Charles Burlingame, M.D. Award Lecture. Hartford, CT: The Institute for Living, 1990.
4. Deutsch CK, Swanson JM, Bruell JH, Cantwell DP, Weinberg F, Baren M. Over representation of adoptees in children with attention deficit disorder. Behav Genet 1982;12:231238.
5. Posner MI, Raichle ME. Images of mind. Scientific American Books, 1994.
6. Swanson JM, Posner M, Potkin S, et al. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol 1991;6:S119-S127.
7. LaHoste GJ, Swanson JM, Wigal SB, Wigal T, King N, Kennedy JL. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121-124.
8. Swanson JM, Sunohara GA, Kennedy JL, et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998;3:38-41.
9. Swanson JM, Oosterlaan J, Murias M, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci USA 2000;97:4754-4759.
10. Swanson J, Posner M, Cantwell D, et al. Attention-deficit/hyperactivity disorder: symptom domains, cognitive processes and neural networks. In: Parasuraman R, et al., editors. The attentive brain, Boston, MA: MIT Press, 1998. pp. 445-460.
11. American Psychiatric Association. Diagnostic and statistical manual, version IV. Washington, DC: American Psychiatric Association, 1994.
12. World Health Organization. International classification of diseases. 10th ed. Geneva: World Health Organization, 1993.
13. Swanson J, Schuck S, Mann M, et al. Over-identification of extreme behavior in the evaluation and diagnosis of ADHD/HKD. ADHD.net, 2000.
14. Swanson JM, Castellanos XF, Murias M, Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 1998;8:263-271.
15. Swanson J, Grenhill L, Pelham W, Wilens T, Wolraich M, Abikoff H, Atkins M, August G, Biederman J, Bukstein O, Conners K, Efron L, Fiedelkorn K, Fried J, Hoffman M, Lambrecht L, Lerner M, Leventhal B, McBurnett K, Morse E, Palumbo D, Pfiffner L, Stein M, Wigal S, Winans E. J Clin Res 2000;3:59-76.
16. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1088-1096.
17. Deutsch CK, Matthysse S, Swanson JM, Farkas LG. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990;29:189-194.
18. Deutsch CK, Swanson JM, Wigal SB, et al. Embryologically-derived measures of craniofacial dysmorphology in attention-deficit hyperactivity disorder. 2001; submitted.
19. Lou HC. Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxis-haemodynamic encephalopathy. Acta Paediatr 1996;85:1266-1271.
20. Swanson J, McStephen M, Hay D, Levy F, Schuck S. The potential of the SWAN rating scale in genetic analyses of ADHD. Vancouver, BC: International Society for Research in Child Psychopathology, 2000.
21. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Genet 1992;22:337-344.
22. Wilcutt EG, Pennington BF, DeFries JC. Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. Am J Med Genet (Neuropsychiatr Genet) 2000;96:293-301.
23. Crowe RR. Candidate genes in psychiatry: an epidemiological perspective. Am J Med Genet 1993;48(2):74-77.
24. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11:241-247.
25. Collier D, Curran S, Asherson P. Mission: not impossible? Candidate gene studies in child psychiatric disorders. Mol Psychiatry 2000;5:457-460.
26. Cook EH, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993-998.
27. Mitchell R, Howlett S, Earl L, et al. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in the world population. Hum Biol 2000;72:295-304.
28. Swanson J, Flodman P, Kennedy J, et al. Dopamine genes and ADHD 2000. Neurosci Biobehav Rev 2000;24:21-25.
29. Volkow N, Wang G-J, Fowler J, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998;155:1325-1331.
30. Seeman P, Corbett R, Nam D, Van Tol H. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic Parkinsonism. Jpn J Pharmacol 1996;71:187-204.
31. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 1996;98:91-101.
32. Petronis A, Macciardi F, Athanassiades A, et al. Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1994;60:452-455.
33. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 1998;8(2):263-271.
34. Smalley SL, Bailey JN, Palmer CG, et al. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:427-430.
35. Faraone S, Doyle A, Mick E, Biederman J. Meta-analysis of the association between the dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 2001, in press.
36. Sunohara GA, Roberts W, Malone M, et al. Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39(12):1537-1542.
37. McCracken JT, Smalley SL, McGough JJ, et al. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:531-536.
38. Hawi Z, McCarron M, Kirley A, Daly G, Fitzgerald M, Gill M. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet (Neuropsychiatr Genet) 2000;96:268-272.
39. Castellanos FX, Lau E, Tayebi N, et al. Lack of an association between a dopamine-4 receptor polymorphism and attention deficit/ hyperactivity disorder: genetic and brain morphometric analyses. Mol Psychiatry 1998;3:431-434.
40. Rowe D, Stever C, Giedinghagen L, et al. Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder. Mol Psychiatry 1998;3:419-426.
41. Comings DE, Wu S, Chiu C, et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am J Med Genet 1996;67(3):264-288.
42. Eisenberg J, Zohar A, Mei-Tal G, et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD) Am J Med Genet (Neuropsychiatr Genet) 2000;96:258-261.
43. Kotler M, Manor I, Sever Y, et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet (Neuropsychiatr Genet) 2000;96:278-281.
44. Holmes J, Payton A, Barrett J, et al. A family-based can case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000;5:523-530.
45. Epstein R, Novick O, Umansky R, et al. Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 1996;12:78-80.
46. Epstein R, Levine J, Geller V, Auerbach J, Gritsenko I, Belmaker R. Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry 1998;3:238-246.
47. Ekelund J, Lichtermann D, Jarvelin M-R, Peltonen L. Association between novelty seeking and the type 4 dopamine receptor gene in a large Finnish cohort sample. Am J Psychiatry 1999;156:1453-1455.
48. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. J Neurochem 1995;65(3):1157-1165.
49. 4.10 receptor variants. Pharmacogenetics 1999;9:561-568.
50. Swanson JM, Oosterlaan J, Murias M, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc Natl Acad Sci USA 2000;97:4754-4759.
51. Morton J, Frith U. Causal modeling: a structural approach to developmental psychopathology. In: Cicchetti D, Cohen D, editors. Manual of developmental psychopathology, vol 1. 1995. pp. 357-390.
52. Wender PH. Minimal brain dysfunction in children. New York: Wiley-Interscience, 1971.
53. Jensen P, Mrazek D, Knapp D, et al. Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. J Am Acad Child Adolesc Psychiatry 1997;36:1672-1681.
54. Leckman JF, Mayes LC. Understanding developmental psychopathology: how useful are evolutionary accounts? J Am Acad Child Adolesc Psychiatry 1998;37:1011-1021.
55. Pani L. Is there an evolutionary mismatch between the normal physiology of the human dopaminergic system and current environmental conditions in industrialized countries? Mol Psychiatry 2000;5:467-475.
56. Chen C, Burton M, Greenberger E, Dmitrieva J. Population migration and the variation of dopamine D4 receptor (DRD4) allele frequencies around the globe. Evol Hum Behav 1999;20:309-324.
57. Kidd K, Black F, Weiss K, Balazs I, Kidd K. Studies of three Amerindian populations using nuclear DNA polymorphisms. Hum Biol 1991;63:775-794.
58. Weiss K. Genetic variation and human disease: principles and evolutionary approaches. Cambridge, UK: Cambridge University Press, 1993.
59. Muglia P, Jain U, Macciardi F, Kennedy JL. Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet (Neuropsychiatr Genet) 2000;96:273-277.
60. Barr CL, Wigg KG, Schachar R, Tannock R, Roberst W, Malone M, Kennedy JL. 5′-Untranslated region of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Med Genet, in press.
61. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment of the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993;26(6):767-773.
62. Livak KJ, Rogers J, Lichter JB. Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proc Natl Acad Sci USA 1995;92:427-431.
63. Moyzis R, Swanson J, Ding Y, et al. Sequence variation in exon 3 of the DRD4 gene: implications for ADHD. Vancouver, BC: International Society for Research in Child Psychopathology, 2001.
64. Terwilliger JD, Weiss HHH. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum Biol 2000;72:63-132.
65. Mol Psychiatry 2000;5:457-460.
66. Wilson M. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2000;24:51-57.
67. Barr CL, Feng Y, Wigg K, et al. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention deficit hyperactivity disorder. Mol Psychiatry 2000;5:405-409.
68. Gainetdinov R, Wetsel W, Jones S, Levin E, Jaber M, Caron M. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999;283:397-401.
69. Quist J, Barr C, Schachar R, et al. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Mol Psychiatry 2000;5:537-541.
70. Eisenberg J, Mei-Tal G, Steinberg A, et al. Halpotype relative risk study of catechol-o-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 1999;88:497-502.
71. Manor I, Kotler M, Sever Y, et al. Failure to replicate an association between the catechol-o-methyltransferase polymorphism and attention deficit hyperactivity disorder in a second, independently recruited Israeli cohort. Am J Med Genet (Neuropsychiatr Genet) 2000;96:858-860.
72. Barr C, Wigg K, Malone M, et al. Linkage study of catechol-o-methyltransferase and attention deficit-hyperactivity disorder. Am J Med Genet (Neuropsychiatr Genet) 1999;88:710-713.
73. The ADHD Molecular Genetics Network. Am J Med Genet (Neuropsychiatr Genet) 2000;96:251-257.
74. Curran S, Newman S, Taylor E, Asherson P. Hypescheme: an operational criteria checklist and minimal data set for molecular genetic studies of attention deficit and hyperactivity disorders. Am J Med Genet (Neuropsychiatr Genet) 2000;96:244-250.